Learn about the Latest Therapy Approved by the FDA for Gastroesophageal Cancer Patients
A new type of therapy has been approved by [...]
Find out about the Latest in Advancements for Esophageal Cancer Treatment
ECAN will host a free webinar on Tuesday, March [...]
FDA approves New Therapy Aimed at a New Target in Esophageal Cancer at the GE Junction
The Food and Drug Administration (FDA) has approved Zolbetuximab [...]
Study finds Regimen that doesn’t include Radiation is Better than current Standard
A German study finds a 30% reduction in the [...]
FDA Advisory Panel votes to limit some EC patients’ access to immunotherapy
In 2021, Esophageal Cancer patients and advocates celebrated the [...]
Powerful Tool to Catch Esophageal Cancer Before It Starts
A newly released study of the benefits of the [...]
Five-Year Data on Immunotherapy for Advanced Esophageal Cancer Shows Tripling of Survival Rate
At the 2024 American Society of Clinical Oncology Gastrointestinal [...]
New Discovery: Inherited Gene Mutation linked to Esophageal Adenocarcinoma
A breakthrough by researchers at Case Western Reserve has led [...]
ECAN Launches New, Animated Guide for Patients at Risk for Esophageal Cancer
With animations that illustrate how to prevent, detect, treat, and [...]
New, Free Clinical Trials Matching
ECAN is proud to launch a new, personalized service [...]
Beta Blockers to Improve Immunotherapy Response
Less than a third of Esophageal Cancer Patients Respond [...]
Study finds Drug Increases Appetite, Weight Gain for Cancer Patients
Low doses of an inexpensive, well-tolerated drug were found to [...]